Showing results (1981-1990 of 2,389) with videos related to

Sort By:
Pageof 239
Transplantation and Cellular Therapy|September 27, 2021
Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with HistopathologyRachel E Reingold, Jilliana Monnier, Marco Ardigò, et al.
American Journal of Epidemiology|March 31, 2016
Air Pollution Exposure During Pregnancy and Fetal Markers of Metabolic function: The MIREC StudyEric Lavigne, Jillian Ashley-Martin, Linda Dodds, et al.
Journal of Neuroendocrinology|February 19, 2019
Age-specific associations between oestradiol, cortico-amygdalar structural covariance, and verbal and spatial skillsTuong-Vi Nguyen, Sherri Lee Jones, Tricia Gower, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trialPierre Fumoleau, Pierre Kerbrat, Pascale Romestaing, et al.
Annals of Intensive Care|April 10, 2024
Oxygenation management during veno-arterial ECMO support for cardiogenic shock: a multicentric retrospective cohort studyHadrien Winiszewski, Thibault Vieille, Pierre-Grégoire Guinot, et al.
The New England Journal of Medicine|October 29, 2025
Deferring Arterial Catheterization in Critically Ill Patients with ShockGrégoire Muller, Damien Contou, Stephan Ehrmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 TrialHenri Roché, Pierre Fumoleau, Marc Spielmann, et al.
Diabetologia|March 15, 2024
Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetesDakota Gustafson, Peter V DiStefano, Xue Fan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer GroupHenning Mouridsen, Mikhail Gershanovich, Yan Sun, et al.
Pageof 239